Pentraxins

CRP and PTX3 and cardiovascular disease

Yuichiro Maekawa, Toshiyuki Nagai, Atsushi Anzai

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The pentraxins, C-reactive protein (CRP), serum amyloid P (SAP) and pentraxin3 (PTX3) are useful biomarkers for cardiovascular disease (CVD), particularly ischemic heart disease and heart failure, and are deeply involved in the pathogenesis of CVD linked to inflammation and innate immunity. Circulating elevated pentraxins, especially CRP and PTX3 levels can provide prognostic information for a variety of clinical settings and facilitate the diagnosis of CVD. Changes in these levels over time are also important indicators of pharmacological therapy, and may indicate the mechanisms by which pentraxins directly or indirectly affect the pathophysiology of CVD in an experimental setting. Here, we discuss major relevant findings associated with the clinical implications of CRP and PTX3 and their role in CVD.

Original languageEnglish
Pages (from-to)229-235
Number of pages7
JournalInflammation and Allergy - Drug Targets
Volume10
Issue number4
Publication statusPublished - 2011 Aug

Fingerprint

C-Reactive Protein
Cardiovascular Diseases
Amyloid
Innate Immunity
Myocardial Ischemia
Heart Failure
Biomarkers
Pharmacology
Inflammation
Serum
Therapeutics

Keywords

  • C-reactive protein
  • Cardiovascular disease
  • Pentraxin3

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pharmacology

Cite this

Pentraxins : CRP and PTX3 and cardiovascular disease. / Maekawa, Yuichiro; Nagai, Toshiyuki; Anzai, Atsushi.

In: Inflammation and Allergy - Drug Targets, Vol. 10, No. 4, 08.2011, p. 229-235.

Research output: Contribution to journalArticle

Maekawa, Yuichiro ; Nagai, Toshiyuki ; Anzai, Atsushi. / Pentraxins : CRP and PTX3 and cardiovascular disease. In: Inflammation and Allergy - Drug Targets. 2011 ; Vol. 10, No. 4. pp. 229-235.
@article{f3c43112cd2a406c98dee2770981e4bf,
title = "Pentraxins: CRP and PTX3 and cardiovascular disease",
abstract = "The pentraxins, C-reactive protein (CRP), serum amyloid P (SAP) and pentraxin3 (PTX3) are useful biomarkers for cardiovascular disease (CVD), particularly ischemic heart disease and heart failure, and are deeply involved in the pathogenesis of CVD linked to inflammation and innate immunity. Circulating elevated pentraxins, especially CRP and PTX3 levels can provide prognostic information for a variety of clinical settings and facilitate the diagnosis of CVD. Changes in these levels over time are also important indicators of pharmacological therapy, and may indicate the mechanisms by which pentraxins directly or indirectly affect the pathophysiology of CVD in an experimental setting. Here, we discuss major relevant findings associated with the clinical implications of CRP and PTX3 and their role in CVD.",
keywords = "C-reactive protein, Cardiovascular disease, Pentraxin3",
author = "Yuichiro Maekawa and Toshiyuki Nagai and Atsushi Anzai",
year = "2011",
month = "8",
language = "English",
volume = "10",
pages = "229--235",
journal = "Current Drug Targets: Inflammation and Allergy",
issn = "1871-5281",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Pentraxins

T2 - CRP and PTX3 and cardiovascular disease

AU - Maekawa, Yuichiro

AU - Nagai, Toshiyuki

AU - Anzai, Atsushi

PY - 2011/8

Y1 - 2011/8

N2 - The pentraxins, C-reactive protein (CRP), serum amyloid P (SAP) and pentraxin3 (PTX3) are useful biomarkers for cardiovascular disease (CVD), particularly ischemic heart disease and heart failure, and are deeply involved in the pathogenesis of CVD linked to inflammation and innate immunity. Circulating elevated pentraxins, especially CRP and PTX3 levels can provide prognostic information for a variety of clinical settings and facilitate the diagnosis of CVD. Changes in these levels over time are also important indicators of pharmacological therapy, and may indicate the mechanisms by which pentraxins directly or indirectly affect the pathophysiology of CVD in an experimental setting. Here, we discuss major relevant findings associated with the clinical implications of CRP and PTX3 and their role in CVD.

AB - The pentraxins, C-reactive protein (CRP), serum amyloid P (SAP) and pentraxin3 (PTX3) are useful biomarkers for cardiovascular disease (CVD), particularly ischemic heart disease and heart failure, and are deeply involved in the pathogenesis of CVD linked to inflammation and innate immunity. Circulating elevated pentraxins, especially CRP and PTX3 levels can provide prognostic information for a variety of clinical settings and facilitate the diagnosis of CVD. Changes in these levels over time are also important indicators of pharmacological therapy, and may indicate the mechanisms by which pentraxins directly or indirectly affect the pathophysiology of CVD in an experimental setting. Here, we discuss major relevant findings associated with the clinical implications of CRP and PTX3 and their role in CVD.

KW - C-reactive protein

KW - Cardiovascular disease

KW - Pentraxin3

UR - http://www.scopus.com/inward/record.url?scp=79959936662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959936662&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 229

EP - 235

JO - Current Drug Targets: Inflammation and Allergy

JF - Current Drug Targets: Inflammation and Allergy

SN - 1871-5281

IS - 4

ER -